EG Capital Advisors is a privately owned investment manager.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
EG Capital Advisors has a strong emerging markets pedigree, global reach and proven track-record catering to the demands of wholesale and institutional investors worldwide. The firm’s value creation is based on rigorous investment analysis, prudent risk management, in-depth research and continued client relevance. EG Capital Advisors’ solid track-record underpins the commitment of their investor base and manifests their unrivalled unique bottom-up alpha generation approach. EG Capital Advisors’ objective is to continuously generate high current yield returns across the existing asset classes, and form strategic partnerships globally in search of growth opportunities and new investment ideas.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2015 | Prosper Marketplace | Series D | 0 |
4/2017 | Valens Semiconductor | Series D | 60M |
11/2015 | RetroSense Therapeutics | Series B | 0 |
3/2017 | NFWare | Seed Round | 0 |
4/2015 | Prosper Marketplace | Secondary Market | - |
9/2015 | ADC Therapeutics | Series C | 0 |
11/2015 | CloudEndure | Series B | 0 |
8/2017 | Dianrong | Series D | 220M |
8/2015 | Dianrong | Series C | 0 |
4/2014 | IHS Towers | Private Equity Round | 0 |
5/2013 | Numecent | Series B | 13.6M |
6/2017 | Coursera | Series D | 0 |
3/2017 | Medisafe | Series B | 0 |
9/2013 | Medisafe | Seed Round | 1M |
8/2017 | Dianrong | Series D | 0 |
6/2017 | Coursera | Series D | 0 |
4/2017 | Valens Semiconductor | Series D | 0 |
3/2017 | NFWare | Seed Round | 0 |
3/2017 | Medisafe | Series B | 0 |
11/2015 | RetroSense Therapeutics | Series B | 0 |
11/2015 | CloudEndure | Series B | 0 |
9/2015 | ADC Therapeutics | Series C | 0 |
8/2015 | Dianrong | Series C | 0 |
4/2015 | Prosper Marketplace | Secondary Market | - |
Name | Price |
---|
Name | Size | Announced Date |
---|